More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...

A European medical regulator says it has found a possible link to the cause of the extremely rare blood clot disorder, tied to the Johnson and Johnson vaccine. It's the potential finding that medical ...

What Is Cablivi, and Why Does It Matter? Cablivi (caplacizumab) is an injectable medicine used to treat a rare and serious blood condition called acquired thrombotic thrombocytopenic purpura (aTTP).

Program Includes a First-of-Its-Kind National Writing Scholarship for Women Affected by Blood Clots and Clotting ...

Tulane University biomedical engineers are testing a new device designed to rapidly detect life-threatening blood-clotting problems in trauma patients, potentially reducing diagnostic time from hours ...

WASHINGTON — The Food and Drug Administration has approved the first drug treatment for pediatric patients 12 and older with a rare blood disorder. The treatment for acquired thrombotic ...